NVDA gained a massive 197% since our AI first added it in November - is it time to sell? 🤔Read more

Top Wall Street Forecasters Revamp FactSet Research Expectations Ahead Of Q3 Earnings

Published 21/06/2024, 10:13
© Reuters.  Top Wall Street Forecasters Revamp FactSet Research Expectations Ahead Of Q3 Earnings
FDS
-

Benzinga - by Avi Kapoor, Benzinga Staff Writer.

FactSet Research Systems Inc. (NYSE:FDS) is set to release third quarter financial results, before the opening bell on Friday.

Analysts expect the Norwalk, Connecticut-based company to report quarterly earnings at $3.90 per share, up from $3.79 per share in the year-ago period. FactSet Research is expected to post revenue of $552.71 million, according to data from Benzinga Pro.

On May 2, FactSet's board approved a 6% increase in the regular quarterly cash dividend of 98 cents per share to $1.04 per share.

FactSet Research shares gained 0.3% to close at $408.35 on Thursday.

Benzinga readers can access the latest analyst ratings on the Analyst Stock Ratings page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.

Let's have a look at how Benzinga's most-accurate analysts have rated the company in the recent period.

  • Morgan Stanley analyst Toni Kaplan maintained an Underweight rating and cut the price target from $372 to $350 on June 3. This analyst has an accuracy rate of 75%.
  • Wolfe Research analyst Scott Wurtzel initiated coverage on the stock with an Underperform rating and a price target of $430 on April 11. This analyst has an accuracy rate of 69%.
  • BMO Capital analyst Jeffrey Silber maintained a Market Perform rating and raised the price target from $447 to $458 on March 25. This analyst has an accuracy rate of 71%.
  • Stifel analyst Shlomo Rosenbaum reiterated a Hold rating with a price target of $469 on March 22. This analyst has an accuracy rate of 67%.
  • Barclays analyst Manav Patnaik downgraded the stock from Overweight to Equal-Weight rating and cut the price target from $480 to $460 on March 22. This analyst has an accuracy rate of 76%.
Read This Next: Top 4 Consumer Stocks that May Keep You Up At Night This Month

Latest Ratings for FDS

DateFirmActionFromTo
Feb 2022Morgan StanleyMaintainsUnderweight
Jan 2022Morgan StanleyMaintainsUnderweight
Dec 2021Morgan StanleyMaintainsUnderweight
View More Analyst Ratings for FDS

View the Latest Analyst Ratings

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.